HK1057474A1 - Medicinal composition - Google Patents

Medicinal composition

Info

Publication number
HK1057474A1
HK1057474A1 HK04100314A HK04100314A HK1057474A1 HK 1057474 A1 HK1057474 A1 HK 1057474A1 HK 04100314 A HK04100314 A HK 04100314A HK 04100314 A HK04100314 A HK 04100314A HK 1057474 A1 HK1057474 A1 HK 1057474A1
Authority
HK
Hong Kong
Prior art keywords
medicinal composition
medicinal
composition
Prior art date
Application number
HK04100314A
Inventor
Hiroshi Kikuchi
Michiko Iketani
Hideo Kobayashi
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Publication of HK1057474A1 publication Critical patent/HK1057474A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1611Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
HK04100314A 2000-09-19 2004-01-15 Medicinal composition HK1057474A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000283565 2000-09-19
PCT/JP2001/008137 WO2002024167A1 (en) 2000-09-19 2001-09-19 Medicinal composition

Publications (1)

Publication Number Publication Date
HK1057474A1 true HK1057474A1 (en) 2004-04-08

Family

ID=18767909

Family Applications (1)

Application Number Title Priority Date Filing Date
HK04100314A HK1057474A1 (en) 2000-09-19 2004-01-15 Medicinal composition

Country Status (12)

Country Link
US (2) US20040022848A1 (en)
EP (1) EP1319399A1 (en)
JP (3) JPWO2002024167A1 (en)
KR (1) KR20030040389A (en)
CN (1) CN1247188C (en)
AU (1) AU2001290239A1 (en)
CA (1) CA2419434A1 (en)
HK (1) HK1057474A1 (en)
NO (1) NO20031246D0 (en)
RU (1) RU2281757C2 (en)
TW (1) TWI290053B (en)
WO (1) WO2002024167A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8101209B2 (en) * 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
KR100712356B1 (en) * 2003-01-23 2007-05-02 (주)아모레퍼시픽 Sustained-release preparations and method for producing the same
DE10323759A1 (en) * 2003-05-22 2004-12-16 Bauer, Wulf, Dr. Remedies for internal use, especially against cancer
JP4808392B2 (en) * 2003-09-04 2011-11-02 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Pharmacological composition concealing bitterness
JPWO2006059716A1 (en) * 2004-12-03 2008-06-05 武田薬品工業株式会社 Solid preparation
US8524734B2 (en) 2005-05-18 2013-09-03 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
DK1901749T3 (en) * 2005-05-18 2016-10-24 Raptor Pharmaceuticals Inc Aerosolized fluoroquinolones AND USES THEREOF
US20070224323A1 (en) * 2006-03-23 2007-09-27 Fred Goldman Sugar Replacement and Baked Goods and Caramels Using the Sugar Replacement
MX2009008935A (en) 2007-02-23 2009-11-02 Gilead Sciences Inc Modulators of pharmacokinetic properties of therapeutics.
JP2011153075A (en) * 2008-04-04 2011-08-11 Shionogi & Co Ltd Fine granule having improved suspension performance in water
EA201591353A1 (en) * 2008-05-02 2016-01-29 Джилид Сайэнс, Инк. APPLICATION OF PARTICLES OF A SOLID MEDIA FOR IMPROVEMENT OF TECHNOLOGICAL CHARACTERISTICS OF THE PHARMACEUTICAL AGENT
KR20110091510A (en) 2008-10-07 2011-08-11 엠펙스 파마슈티컬즈, 인코포레이티드 Aerosol fluoroquinolone formulations for improved pharmacokinetics
CA2739893C (en) 2008-10-07 2016-10-04 Mpex Pharmaceuticals, Inc. Inhalation of levofloxacin for reducing lung inflammation
RU2015130524A (en) 2009-09-04 2018-12-21 Раптор Фармасьютикалз Инк. The use of levofloxacin in the form of an aerosol for the treatment of cystic fibrosis
JP2013032289A (en) * 2009-10-28 2013-02-14 Daiichi Sankyo Co Ltd Wax stable formulation
US10842802B2 (en) * 2013-03-15 2020-11-24 Medicis Pharmaceutical Corporation Controlled release pharmaceutical dosage forms
PT108978B (en) * 2015-11-24 2020-03-09 Hovione Farm S A TETRACYCLINE SALTS

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2915590B2 (en) * 1991-02-15 1999-07-05 第一製薬株式会社 Masked granules
JP3130058B2 (en) * 1991-02-15 2001-01-31 第一製薬株式会社 Masked granules
JP2915653B2 (en) * 1991-11-14 1999-07-05 第一製薬株式会社 Masked granules
JP3265680B2 (en) * 1992-03-12 2002-03-11 大正製薬株式会社 Oral pharmaceutical composition
DE69432186T2 (en) * 1993-11-18 2004-05-06 Nippon Shinyaku Co., Ltd. METHOD FOR PRODUCING STABLE MEDICINAL PRODUCTS
DK0826376T3 (en) * 1995-05-02 2007-04-16 Taisho Pharmaceutical Co Ltd Composition for oral administration
JPH0995439A (en) * 1995-09-29 1997-04-08 Eisai Co Ltd Production of solid preparation
US6235947B1 (en) * 1997-04-14 2001-05-22 Takeda Chemical Industries, Ltd. D-mannitol and its preparation
JP3126683B2 (en) * 1996-04-16 2001-01-22 武田薬品工業株式会社 D-mannitol and method for producing the same
ID16566A (en) * 1996-04-16 1997-10-16 Takeda Chemical Industries Ltd D-MANITOL AND IT'S MANUFACTURING
CN1158071C (en) * 1997-05-30 2004-07-21 渗透有限公司 Multi-layered osmotic device
KR100768034B1 (en) * 1999-03-17 2007-10-17 다이이찌 세이야꾸 가부시기가이샤 Pharmaceutical composition
US6383471B1 (en) * 1999-04-06 2002-05-07 Lipocine, Inc. Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
JP2001270821A (en) * 2000-03-23 2001-10-02 Eisai Co Ltd Powder medicine having excellent taking easiness
JP2001302497A (en) * 2000-04-21 2001-10-31 Eisai Co Ltd Powdery preparation excellent in miscibility

Also Published As

Publication number Publication date
US20070196504A1 (en) 2007-08-23
CN1455665A (en) 2003-11-12
CA2419434A1 (en) 2003-02-07
CN1247188C (en) 2006-03-29
JP2014132022A (en) 2014-07-17
WO2002024167A1 (en) 2002-03-28
NO20031246L (en) 2003-03-18
AU2001290239A1 (en) 2002-04-02
RU2281757C2 (en) 2006-08-20
JP2012158610A (en) 2012-08-23
US20040022848A1 (en) 2004-02-05
EP1319399A1 (en) 2003-06-18
NO20031246D0 (en) 2003-03-18
JPWO2002024167A1 (en) 2004-01-29
TWI290053B (en) 2007-11-21
KR20030040389A (en) 2003-05-22

Similar Documents

Publication Publication Date Title
EG24357A (en) New Pharmaceutical composition
IL152659A0 (en) Pharmaceutical composition
HK1075889A1 (en) Pharmaceutical composition
GB2358582B (en) Pharmaceutical compositions
HUP0204555A3 (en) Pharmaceutical composition
AU6219601A (en) Pharmaceutical compositions
GB0009584D0 (en) Pharmaceutical compositions
HK1065257A1 (en) Medicinal composition
AU8576801A (en) Pharmaceutical compositions
HK1057474A1 (en) Medicinal composition
GB0002386D0 (en) Therapeutic composition
IL154238A0 (en) Pharmaceutical composition
GB0008485D0 (en) Pharmaceutical compositions
GB0009613D0 (en) Pharmaceutical compositions
GB0005382D0 (en) Pharmaceutical composition
GB0114746D0 (en) Medicinal composition
AU8254101A (en) Medicinal compositions
GB0101094D0 (en) Pharmaceutical composition
GB0002691D0 (en) Pharmaceutical composition
GB0026716D0 (en) Pharmaceutical composition
GB0006301D0 (en) Pharmaceutical composition
GB0016684D0 (en) Pharmaceutical composition
GB0019599D0 (en) Pharmaceutical composition
GB0027375D0 (en) Pharmaceutical composition
GB0003929D0 (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20090919